Ilaria Bacigalupo Selected Research

HIV Protease Inhibitors

5/2017	Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.
10/2014	The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells.
1/2011	Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
2/2009	Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.
2/2003	[HIV protease inhibitors for the treatment of Kaposi's sarcoma].
11/2002	Treatment of Kaposi's sarcoma--an update.
3/2002	HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilaria Bacigalupo Research Topics

Disease

6	Neoplasms (Cancer) 10/2016 - 11/2002
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2019
4	Kaposi Sarcoma (Kaposi's Sarcoma) 02/2009 - 03/2002
3	Dementia (Dementias) 09/2021 - 05/2017
3	Disease Progression 05/2017 - 02/2009
3	Carcinoma (Carcinomatosis) 05/2017 - 05/2012
3	Infections 01/2012 - 11/2002
2	Cognitive Dysfunction 01/2022 - 01/2019
2	HIV Infections (HIV Infection) 09/2021 - 05/2012
2	COVID-19 09/2021 - 01/2021
2	Uterine Cervical Dysplasia 05/2017 - 05/2012
1	Asthma (Bronchial Asthma) 09/2021
1	Autoimmune Diseases (Autoimmune Disease) 09/2021
1	Hypersensitivity (Allergy) 09/2021
1	Multiple Sclerosis 09/2021
1	Respiratory Insufficiency (Respiratory Failure) 09/2021
1	Respiratory Sounds (Crackle) 09/2021
1	Neurocognitive Disorders (Clerambault Syndrome) 09/2021
1	Chronic Renal Insufficiency 09/2021
1	Frailty 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Adenocarcinoma 01/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2002

Drug/Important Bio-Agent (IBA)

7	HIV Protease InhibitorsIBA 05/2017 - 03/2002
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2009
3	Pharmaceutical PreparationsIBA 09/2021 - 02/2003
3	Saquinavir (Invirase)FDA Link 05/2017 - 01/2011
3	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 01/2011
3	Indinavir (Crixivan)FDA Link 05/2012 - 02/2009
3	CytokinesIBA 08/2011 - 11/2002
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	Ritonavir (Norvir)FDA Link 05/2017 - 05/2012
2	Trans-Activators (Trans-Acting Factor)IBA 10/2016 - 04/2006
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2011 - 11/2002
1	Monoclonal AntibodiesIBA 01/2022
1	Oxygen (Dioxygen)IBA 09/2021
1	Antiviral Agents (Antivirals)IBA 09/2021
1	CreatinineIBA 09/2021
1	InterferonsIBA 09/2021
1	Interferon-betaIBA 09/2021
1	Biological ProductsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	florbetapirIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 10/2016
1	tat Gene Products (tat Protein)IBA 10/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2014
1	IntegrinsIBA 01/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2011
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2009
1	EnzymesIBA 02/2003
1	Human immunodeficiency virus 1 p16 proteaseIBA 03/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2002
1	Drug Therapy (Chemotherapy) 09/2021
1	Artificial Respiration (Mechanical Ventilation) 09/2021
1	Long-Term Care 01/2021
1	Secondary Prevention 05/2017
1	Highly Active Antiretroviral Therapy (HAART) 05/2012